Risk of death among chronic dialysis patients infected with hepatitis C virus.

@article{StehmanBreen1998RiskOD,
  title={Risk of death among chronic dialysis patients infected with hepatitis C virus.},
  author={C. Stehman-Breen and S. Emerson and D. Gretch and R. Johnson},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={1998},
  volume={32 4},
  pages={
          629-34
        }
}
Hepatitis C virus (HCV) infection is highly prevalent among chronic dialysis patients (10% to 40%) and is the most common cause of chronic liver disease. However, there are no studies estimating the risk for death among dialysis patients infected with HCV compared with those not infected. We conducted a prospective cohort study to estimate the risk for death among chronic dialysis patients infected with HCV compared with those not infected. In 1992, 200 patients (91%) who had been undergoing… Expand

Paper Mentions

Interventional Clinical Trial
Chronic hepatitis C virus (HCV) infection is common in dialysis patients. Interferon (IFN)-based treatment for chronic hepatitis C has been the mainstay therapy in… Expand
ConditionsChronic Hepatitis C
InterventionDrug
Interventional Clinical Trial
Chronic hepatitis C virus (HCV) infection is common in dialysis patients. Interferon (IFN)-based treatment for chronic hepatitis C has been the mainstay therapy in… Expand
ConditionsChronic Hepatitis C, Hemodialysis
InterventionDrug
Mortality in Hepatitis C-Positive Patients Treated with Peritoneal Dialysis
TLDR
The results show that the HCV-positive PD patients had a higher 10-year mortality rate than the HCv-negative PD patients, and the association between HCV infection and mortality was independent of diabetes. Expand
Hepatitis C-related liver disease in dialysis patients.
TLDR
Evidence supports the notion that the progression of HCV-related liver disease is probably slower in the dialysis population than in non-uremic patients despite the immune compromise conferred from chronic uremia; numerous mechanisms have been mentioned to explain it. Expand
Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
TLDR
The rate of graft loss was higher in HCV (+) patients, whereas the patient survival was similar in both groups, according to the aim of this study. Expand
Hepatitis C virus and death risk in hemodialysis patients.
TLDR
In maintenance hemodialysis patients, HCV infection exhibits distinct demographic, clinical, and laboratory patterns, including associations with higher dialysis treatment vintage, and is associated with higher mortality. Expand
Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients
Background: Hepatitis C virus (HCV) infection is associated with increased mortality among hemodialysis (HD) patients. Guidelines from Kidney Disease: Improving Global Outcomes recommend thatExpand
Hepatitis C Virus Infection and Dialysis: 2012 Update
TLDR
It has been suggested that the decision to treat HCV in patients with chronic kidney disease be based on the potential benefits and risks of therapy, including life expectancy, candidacy for kidney transplant, and co-morbidities. Expand
Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.
TLDR
An increased risk of death among long-term haemodialysis patients infected with HCV compared with non-infected patients is shown and might be partly explained by the high proportion of these patients that evolve to liver cirrhosis. Expand
Hepatitis C in dialysis patients.
TLDR
Interferon alpha (standard or pegylated) is the current treatment of HCV infection in dialysis patients, with careful patient selection together with a close follow-up of the main side effect. Expand
Hepatitis Status and Mortality in Hemodialysis Population
TLDR
The results suggest that HCV positivity among MHD patients is associated with significantly higher mortality in female aged <65 years, and should be more aggressive in identifying, preventing, and treating HCV infection among patients with end stage renal disease. Expand
Clinical outcomes of Renal Transplantation in Hepatitis C virus positive recipients.
TLDR
The short term patient and graft survival of HCV positive recipients of hepatitis C virus positive renal transplantation recipients was better and the all cause mortality among hepatitis c virus positive recipients was not statistically significant. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
HEPATITIS C—ITS PREVALENCE IN END‐STAGE RENAL FAILURE PATIENTS AND CLINICAL COURSE AFTER KIDNEY TRANSPLANTATION
TLDR
The presence of anti-HCV should not be a contraindication for kidney transplantation, based on results from a descriptive crosssectional study of all renal failure patients admitted for kidney transplants between 1/84 and 12/88. Expand
High incidence of hepatitis C virus infection in hemodialysis patients in Taiwan.
TLDR
The longer the patient underwent hemodialysis, the higher the anti-HCV positive rate became, which did not seem to be related to transfusions, and it is concluded that HCV infection is the main cause of hepatitis in he modialysis. Expand
Hepatitis C and Hepatitis B Virus Infection in Hemodialysis Patients and Staff: A Two Year Follow-Up
TLDR
There was a significant difference in the prevalence of anti-HCV and anti-HBc positivity between polytransfused and occasionally transfused patients (p<0.05) and during a 24-months follow-up a decline was observed in HBs antigen carriers from 20% to 10% and in HBc antibody carriers from 47% to 33%. Expand
Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences in viral load.
  • D. DuBois, D. Gretch, +4 authors L. Corey
  • Medicine
  • American journal of kidney diseases : the official journal of the National Kidney Foundation
  • 1994
TLDR
Intravenous drug abuse was the most frequently identified risk factor for infection with HCV in this population of hemodialysis patients and no association between HCV RNA levels and hepatic enzyme levels was apparent. Expand
Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus.
Between January 1987 and October 1988, 35 (45%) of 77 patients undergoing chronic hemodialysis at one unit developed serum alanine aminotransferase (ALT) elevations suggestive of non-A, non-BExpand
Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays
TLDR
Good correlation was found between the results of antibody to hepatitis C virus detection on second‐generation enzyme immunoassay and of hepatitisC virus RNA by nested polymerase chain reaction and it was found that serum transaminase level is a poor indicator of hepatitis Cirus infection in hemodialysis patients. Expand
Prevalence of anti‐HCV and HCV viremia in hemodialysis patients in Taiwan
TLDR
It is concluded that the high prevalence of specific HCV infection and HCV viremia was present in these patients and prevention of cross‐ contamination during dialysis and blood screen‐ ing before transfusion are important for the control of HCV infected patients. Expand
Hepatitis C infection in two urban hemodialysis units.
TLDR
The results of this serologic survey suggests that anti-HCV positivity is prevalent, although much less than anti-HBc, among the authors' dialysis patients, whereas it was not detected among staff members. Expand
Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
TLDR
The result implies that both HBV and HCV are independent risk factors for cirrhotic HCC and liver cirrhosis in Taiwan. Expand
Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units.
TLDR
A high prevalence of co-infection with HBV and HCV is detected, suggesting that HCV infection may contribute to chronic liver dysfunction in HD patients. Expand
...
1
2
3
...